Best KRAS, NRAS,BRAF mutation testing Doctors Worldwide — TOP 41

Professor Bulent Karagoz is a medical oncologist at Anadolu Medical Center with a focus on tumor biology and immunology.

• Specializes in targeted therapy to attack specific molecules that help tumors grow
• Former Head of Medical Oncology at GATA Haydarpasa Training Hospital
• Authored over 40 scientific publications focused on immunotherapy and tumor research
• Certified in tumor biology by the Medical Oncology Association
• Uses KRAS, NRAS, and BRAF mutation testing to guide treatment for complex solid tumors

Dr. Mustafa Solak is a clinical oncologist at Hisar Hospital Intercontinental. He specializes in gastrointestinal and lung cancers where KRAS, NRAS, and BRAF mutation testing is essential.

• Trained at MD Anderson Cancer Center – a world leader in cancer research
• Fellowship graduate from the Hacettepe University Cancer Institute
• Expert in targeted therapy based on specific genetic mutations
• Specializes in treating colon, pancreatic, and lung malignancies
• Experienced in using immunotherapy drugs like Keytruda for advanced cases

Dr. Tanrikulu ranked 3rd nationwide in Turkey’s specialty exam and leads oncology at Anadolu Medical Center. She uses genetic testing to tailor targeted therapies for colon and lung cancers.

• Completed metastatic colorectal cancer training at Oxford University in England
• Former Head of the Oncology Unit at Haydarpaşa Numune Training and Research Hospital
• Lead researcher in international clinical trials for cancer treatments
• Member of ASCO, the leading global organization for cancer professionals
• Specializes in matching specific therapies to a tumor’s unique genetic profile

Dr. Abdulcabbar Kartal is a certified Fellow of the European Board of Surgery. He specializes in gastrointestinal cancers where KRAS, NRAS, and BRAF mutation testing guides treatment.

• Treats stomach, colon, and small intestine cancers at Anadolu Medical Center
• Certified specialist in surgical endoscopy and advanced interventional endoscopic procedures
• Expert in HIPEC – uses heated chemotherapy to treat advanced metastatic cancers
• Member of the European Society of Coloproctology focused on rectal surgery
• Awarded Associate Professor title from Istanbul Okan University faculty of medicine

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Dr. Brenda Pastrana is a surgical oncologist at the JCI-accredited Galenia Hospital in Cancún. She specializes in breast, thyroid, and digestive system cancers. Dr. Pastrana is board-certified by CONACEM. She holds a medical degree from the Universidad Autónoma de México.

• Performs mastectomies, liver resections, and complex colon cancer surgeries.
• Treats patients at a facility holding Accreditation Canada Diamond Status.
• Serves as a university teacher at Universidad Anáhuac.
• Member of the Mexican Society of Oncology (SMEO).

Dr. Agusti Barnadas Molins is the chief breast cancer specialist at Teknon Oncology Institute in Barcelona. He has directed more than 70 research projects on breast cancer and gynecological oncology. Dr. Barnadas Molins treats tumors using chemotherapy, gland therapy, and immunotherapy. He practices at JCI-accredited Centro Médico Teknon.

• Authored over 130 original scientific articles on clinical oncology.
• Served as General Secretary of the Spanish Medical Oncology Society.
• Former President of the Catalan-Balearic Oncology Society.
• Founder and Vice President of the Spanish Breast Cancer Research Group.

Dr. Andreas Sesterhenn is the Chief Physician of Otolaryngology and Plastic Surgery at Solingen Clinic. He specializes in tumor removal for the head, neck, and upper airways. Dr. Sesterhenn uses robotic systems for interventions through incisions as small as 1 cm. Developed expertise in surgical medicine through training in the USA and Germany.

• Performs endoscopic operations through the nose to treat complex tumors.
• Author of over 75 scientific publications in the field of head and neck surgery.
• Treats larynx, thyroid, and tongue cancer using tumor-sparing techniques.
• Works at Solingen Clinic, ranked among the top hospitals in Germany by Focus magazine.

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Sinan Karaaslan specializes in colorectal cancer at Anadolu Medical Center. He uses KRAS, NRAS, and BRAF mutation testing to guide his treatment decisions.

• Treats advanced stage 4 colon and lung cancers
• Uses targeted therapy based on specific genetic mutations found in tumors
• Applies immunotherapy as a modern alternative to traditional systemic treatments
• Former oncology expert at the Gülhane Military Medical Academy
• Member of the Turkish Lung Cancer Society

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Professor Seref Komurcu is an ESMO-certified oncologist at Anadolu Medical Center. He specializes in KRAS, NRAS, and BRAF mutation testing to guide targeted therapy for solid tumors.

• Author of 110 scientific papers on cancer treatment and molecular markers
• Certified by the European Society for Medical Oncology (ESMO) since 1999
• Former Professor of Medical Oncology at Gulhane Military Medical Academy
• Fellowship-level expertise holding a valid US ECFMG medical certification
• Member of the American Society of Clinical Oncology (ASCO)

Professor Necdet Uskent helped perform the first bone marrow transplant in Turkey. He leads oncology and hematology services at Anadolu Medical Center.

• Holds the European Medical Oncology Certificate from ESMO for meeting strict professional standards
• Expertise in KRAS, NRAS, and BRAF mutation testing for gastrointestinal and lung cancers
• Founding member of the Turkish Oncology Group – a leader in national cancer research
• Completed clinical fellowships in oncology and hematology at Wadley Institutes in the USA
• Visiting lecturer at major London hospitals including Westminster and Royal Free

Dr. Ari Raphael is a medical oncologist at Sourasky Medical Center in Tel Aviv. He specializes in thoracic malignancies, lung cancer, and breast cancer. Dr. Raphael won the ISCORT research grant competition for his work in oncology. He serves as a senior lecturer at Tel Aviv University.

• Moderates the Molecular Tumor Board for the Israeli Lung Cancer Society.
• Maintains membership in the European Society of Medical Oncology (ESMO).
• Leads genomic medicine projects focusing on advanced lung cancer treatments.
• Directs the oncology day-care service at Sourasky Medical Center.

Professor Christoph Zielinski leads the Vienna Cancer Center. He uses KRAS, NRAS, and BRAF mutation testing to create personalized treatment plans based on tumor biology.

• Medical Director of the International Oncology Center at Wiener Privatklinik
• Published over 600 scientific papers on cancer genetics and targeted drug therapies
• Former President of the Central European Cooperative Oncology Group
• Specializes in cancer immunotherapy and personalized medicine for melanoma and lung cancer
• Member of the American Society for Clinical Oncology

Dr. Yusuf Acikgoz is a medical oncologist at Lokman Hekim University Ankara Hospital. He specializes in treating complex cancers, including lung, breast, and liver malignancies. He completed a fellowship at Ohio State University in the United States. Dr. Acikgoz manages treatments like chemotherapy, radioembolization, and immunotherapy.

• Member of the American Society of Clinical Oncology (ASCO).
• Assistant Investigator for Phase III clinical trials, including the CheckMate-649 study.
• Certified in Good Clinical Practice and Human Subjects Protection at Ohio State University.
• Performs diagnostic procedures like biopsy, gastroscopy, and tumor marker testing.

Dr. Viola Fox is the Chief Physician at the Clinic for Oncology in Solingen. She is a leading expert in drug therapy for tumors in Germany and Europe. Dr. Fox holds a qualification in specialist genetics and conducts molecular biology research. She treats complex cases at a certified interdisciplinary cancer center.

• Member of the American Association for Cancer Research.
• Specializes in immunotherapy, targeted therapy, and molecular diagnostics.
• Treats hematological diseases, including lymphoma, leukemia, and myeloma.
• Works at Städtisches Klinikum Solingen, a clinic ranked among the top in Germany.